1. Home
  2. MRVI vs WEYS Comparison

MRVI vs WEYS Comparison

Compare MRVI & WEYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRVI
  • WEYS
  • Stock Information
  • Founded
  • MRVI 2014
  • WEYS 1906
  • Country
  • MRVI United States
  • WEYS United States
  • Employees
  • MRVI 560
  • WEYS N/A
  • Industry
  • MRVI Biotechnology: Pharmaceutical Preparations
  • WEYS Apparel
  • Sector
  • MRVI Health Care
  • WEYS Consumer Staples
  • Exchange
  • MRVI Nasdaq
  • WEYS Nasdaq
  • Market Cap
  • MRVI 350.1M
  • WEYS 303.5M
  • IPO Year
  • MRVI 2020
  • WEYS N/A
  • Fundamental
  • Price
  • MRVI $2.42
  • WEYS $30.30
  • Analyst Decision
  • MRVI Hold
  • WEYS
  • Analyst Count
  • MRVI 10
  • WEYS 0
  • Target Price
  • MRVI $5.84
  • WEYS N/A
  • AVG Volume (30 Days)
  • MRVI 1.5M
  • WEYS 14.5K
  • Earning Date
  • MRVI 08-11-2025
  • WEYS 08-05-2025
  • Dividend Yield
  • MRVI N/A
  • WEYS 3.56%
  • EPS Growth
  • MRVI N/A
  • WEYS N/A
  • EPS
  • MRVI N/A
  • WEYS 2.69
  • Revenue
  • MRVI $219,830,000.00
  • WEYS $281,051,000.00
  • Revenue This Year
  • MRVI N/A
  • WEYS N/A
  • Revenue Next Year
  • MRVI $7.23
  • WEYS N/A
  • P/E Ratio
  • MRVI N/A
  • WEYS $11.27
  • Revenue Growth
  • MRVI N/A
  • WEYS N/A
  • 52 Week Low
  • MRVI $1.67
  • WEYS $25.51
  • 52 Week High
  • MRVI $9.60
  • WEYS $41.05
  • Technical
  • Relative Strength Index (RSI)
  • MRVI 49.60
  • WEYS 49.25
  • Support Level
  • MRVI $2.28
  • WEYS $27.83
  • Resistance Level
  • MRVI $2.47
  • WEYS $30.98
  • Average True Range (ATR)
  • MRVI 0.14
  • WEYS 1.27
  • MACD
  • MRVI -0.01
  • WEYS 0.17
  • Stochastic Oscillator
  • MRVI 27.45
  • WEYS 57.71

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

About WEYS Weyco Group Inc.

Weyco Group Inc is a company, engaged in the manufacturing, designing, and distribution of footwear. The company designs and markets footwear for men, women, and children. It markets its apparel, accessories, and footwear under the brand names of Florsheim, Nunn Bush, Stacy Adams, BOGS, Rafters, and Forsake. The company organizes its business into two segments; the North American wholesale operations and the North American retail operations. The majority of the company's revenue is generated from the wholesale segment under which its products are sold to footwear, department, and specialty stores, as well as e-commerce retailers. The company has operational footprints in the United States which generates key revenue, Canada, Asia, South Africa, and Australia.

Share on Social Networks: